scispace - formally typeset
K

Kanhu Charan Das

Researcher at North Eastern Hill University

Publications -  6
Citations -  69

Kanhu Charan Das is an academic researcher from North Eastern Hill University. The author has contributed to research in topics: Adjuvant & Gene. The author has an hindex of 3, co-authored 5 publications receiving 26 citations.

Papers
More filters
Journal ArticleDOI

Draft Genome of the Liver Fluke Fasciola gigantica

TL;DR: The draft genome of Fasciola gigantica presents a comprehensive resource to facilitate the development of novel interventions for fascioliasis control and indicates that the fatty acid required for survival of the fluke may be acquired from the host bile.
Journal ArticleDOI

Design of a multi-epitope subunit vaccine for immune-protection against Leishmania parasite.

TL;DR: The designed peptide-based vaccine construct needs further experimental and clinical investigations to develop it as a safe and effective vaccine against VL infection.
Journal ArticleDOI

Quercetin acts as a P-gp modulator via impeding signal transduction from nucleotide-binding domain to transmembrane domain.

TL;DR: It is shown that quercetin binds in the interacting region between the transmembrane domain and nucleotide-binding domain out of the three plausible binding sites of P-gp and restrict the conformational change from inward- to outward-facing conformation of P -gp.
Journal ArticleDOI

Conserved Arg451 residue is critical for maintaining the stability and activity of thioredoxin glutathione reductase

TL;DR: The current study provided a basis for exploiting regions other than the active site of TGR for inhibitory effect and development of novel antihelminthics and displayed differential dynamics in the FgTGR structure and highlighted the relevance of residue-level interactions in the protein.
Journal ArticleDOI

Genome-wide identification and characterization of eukaryotic protein kinases.

TL;DR: Several FgePKs were found to possess unusual domain architectures, which suggests the diverse nature of the proteins that can be exploited for designing novel inhibitors, further providing a platform for novel structure-based drug designing.